“Spice Up Your Earnings Knowledge: A Recap of McCormick & Company’s Q4 2024 Earnings Call”

Welcome to the McCormick & Company Q4 2024 Earnings Conference Call! Company Participants: Faten Freiha – Vice President, Investor Relations Brendan Foley – Chairman, President and Chief Executive Officer Marcos Gabriel – Executive Vice President and Chief Financial Officer Conference Call Participants: Andrew Lazar – Barclays Peter Galbo – Bank of America Alexia Howard –…

Read More

“FAT Brands Shares Exciting Update for Warrant Holders Regarding Twin Hospitality Spin-Off”

Embracing Change: A Fresh Perspective on FAT Brands’ Spin-off Introduction In a recent announcement on January 23, 2025, FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) revealed plans for a partial spin-off of its subsidiary, Twin Hospitality Group Inc. This move comes in the form of a special stock dividend to FAT Brands’ common stockholders,…

Read More

“Unlocking Hope: Vigil Neurosciences’ Alzheimer’s Treatment Shows Promising Safety Results, Set to Begin Mid-Stage Trial in Q3”

The Latest Breakthrough in Alzheimer’s Disease Treatment Exciting News from Vigil Neuroscience Inc. On Thursday, Vigil Neuroscience Inc. VIGL released data from its completed Phase 1 trial evaluating VG-3927 as a potential treatment for Alzheimer’s disease. Alzheimer’s disease is a devastating condition that affects millions of individuals worldwide. It is a progressive neurodegenerative disorder that…

Read More